|
Indian Journal of Pharmacology
Medknow Publications on behalf of Indian Pharmacological Society
ISSN: 0253-7613 EISSN: 0253-7613
Vol. 42, No. 5, 2010, pp. 320-321
|
Bioline Code: ph10092
Full paper language: English
Document type: Special Article
Document available free of charge
|
|
Indian Journal of Pharmacology, Vol. 42, No. 5, 2010, pp. 320-321
en |
Sitagliptin-induced hemolysis
Bekur, Ragini; Nagaraja, M. V.; Shivashankara, K. N. & Stanley, Weena
Abstract
Sitagliptin is a newer oral hypoglycemic drug of the dipeptidyl peptidase-IV inhibitor class. It appears to be a promising newer oral hypoglycemic agent. The advantages are the absence of hypoglycemia when used as monotherapy and they cause less gain weight. We report a case of sitagliptin-induced hemolysis, a rare side effect, not reported in the literature. As sitagliptin is widely used in type 2 diabetes mellitus physicians should be aware of the possibility of this rare but potentially serious adverse drug reaction.
Keywords
Dipeptidyl peptidase inhibitor, hemolysis, sitagliptin
|
|
© Copyright 2010 Indian Journal of Pharmacology. Alternative site location: http://www.ijp-online.com
|
|